Finance

Lists
HEPA:OTCMKTS
Hepion Pharmaceuticals Inc
0,098 USD
0,00%
(0,00) 1D
15-окт., 13:48:29 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HEPA...
Mkt. cap
12,30 млн
Avg. vol.
35,25 миң
Volume
1,00
52-wk high
0,13 USD
52-wk low
0,03 USD
EPS
-0,24 USD
Beta
1,75
Shares outstanding
98,22 млн
No. of employees
2
Mkt. cap
12,30 млн
Avg. vol.
35,25 миң
Volume
1,00
52-wk high
0,13 USD
52-wk low
0,03 USD
EPS
-0,24 USD
Beta
1,75
Shares outstanding
98,22 млн
No. of employees
2
News stories
From web sources and news partners
About Hepion Pharmaceuticals Inc
CEO-
Employees2
Founded2013
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
70,00 миң
50,92 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
527,90 миң
609,68 миң
728,51 миң
1,16 млн
Operating expense
527,90 миң
609,68 миң
798,51 миң
1,21 млн
Total operating expenses
527,90 миң
609,68 миң
798,51 миң
1,21 млн
Operating income
-527,90 миң
-609,68 миң
-798,51 миң
-1,21 млн
Other non operating income
-
-
-10,15 миң
-42,99 миң
EBT including unusual items
-472,51 миң
-656,88 миң
-810,79 миң
-1,25 млн
EBT excluding unusual items
-519,79 миң
-622,26 миң
-810,79 миң
-1,25 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-472,51 миң
-656,88 миң
-810,79 миң
-1,25 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8,12 миң
-
-
6,24 миң
Interest expense
-
-12,58 миң
-2,13 миң
-
Net interest expenses
8,12 миң
-12,58 миң
-2,13 миң
6,24 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-520,21 миң
-601,99 миң
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору